stocksfeed.ai
← Back to news feed

GSK overview

GSK
GSK plc
48.58
USD
-2.59 (-5.06%)since Nov 16, 2026

News about GSK

2 stories shown

GSKproduct launch

The FDA granted accelerated approval to GSK Plc.’s Nelkarmi for pretreated ALK-positive non-small cell lung cancer, marking the company's second lung cancer drug approval this year.

Benzinga
View original
GSKproduct launch

GSK has received FDA accelerated approval for neladalkib, a lung cancer therapy acquired through its purchase of Nuvalent.

Seeking Alpha
View original